TrialJournal of translational medicine2013

HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial.

Mariette I E van Poelgeest et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.